The efficacy and tolerability of barnidipine hydrochloride in Thai patients with hypertension

Journal of International Medical Research

Volumn 32, Issue 2, 2004, Pages 185-200

  Buranakitjaroen, Peera ^a   Koanantakul, B ^b   Phoojaroenchanachai, M ^a   Chawantanpipat, C ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

Author keywords

Barnidipine; Calcium channel blocker; Efficacy; Hypertension

Indexed keywords

MEPIRODIPINE; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTHRALGIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; MALE; MONOTHERAPY; MULTICENTER STUDY; RECORDING; SIDE EFFECT; SINGLE BLIND PROCEDURE; SWEATING; SYSTOLIC HYPERTENSION; THAILAND;

EID: 1642446583     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000403200212     Document Type: Article

References (33)

1. Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten B, et al: Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354: 1751 - 1756.
2. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, et al: Morbidity and mortality in patients randomised to double-blind treatment with long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366 - 372.
3. Wang JG, Staessen JA, Gong L, Liu L: Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 2000; 160: 211 - 220.
4. Birkenharger WH, Staessen JA, Gasowski J, de Leeuw PW: Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial. J Nephrol 2000; 13: 232 - 237.
5. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755 - 1762.
6. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et al: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999; 340: 677 - 684.
7. Staessen JA, Thijs L, Fagard RH, Birkenhager WH, Arabidze G, Babeanu S, et al: Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension. Hypertension 1998; 32: 404 - 409.
8. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981 - 2997.
9. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, de Cesaris R, Fogari R, et al: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95: 1464 - 1470,
10. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7: 23 - 29.
11. O'Brien E, Atkins N, Staessen J: State of the market. A review of ambulatory blood pressure monitoring devices. Hypertension 1995; 26: 835 - 842.
12. Pickering TG: Blood pressure measurement and detection of hypertension. Lancet 1994; 344: 31 - 35.
13. Asmar R, Zanchetti A: Guidelines for the use of self-blood pressure monitoring: A summary report of the First International Consensus Conference. Groupe Evaluation & Measure of the French Society of Hypertension. J Hypertens 2000; 18: 493 - 508.
14. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P: Blood pressure monitoring. Task force V: White-coat hypertension. Blood Press Monit 1999; 4: 333 - 341.
15. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G: The smoothness index: A new, reproducible and clinically relevant measure of homogeneity of blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16: 1685 - 1691.
16. Rose M, McMahon FG: Some problems with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990; 3: 151 - 155.
17. Meredith PA, ElliottEHL: FDA guidelines on trough:peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration. J Cardiovasc Pharmacol 1994; 23 (Suppl 5): S26 - S30.
18. Myers MG: Suggested guidelines for determining the trough-to-peak ratio of antihypertensive drugs. Am J Hypertens 1996; 9: 76S - 82S.
19. Morgan T (ed): 24-Hour Blood Pressure Control: Its Importance, Its Determination, and The Use of the Trough-To-Peak Ratio. Oxford: Adis International, 1998; pp15 - 28.
20. Neutel JM, Smith DHG, Weber MA: What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring? Blood Press Monit 1999; 4 (Suppl 2): S23 - S28.
21. Liau CS, Chien KL, Chao CL, Lee TM: Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients. J Int Med Res 2002; 30: 330 - 336.
22. Kuwajima I, Abe K for the J-MUBA Study Group: Effects of the long-acting calcium channel blocker barnidipine hydrochloride on 24-h ambulatory blood pressure. Blood Press Monit 2002; 7: 63 - 65.
23. Hart W, Holwerda NJ: Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: A multicenter, double-blind, placebo-controlled, dose-ranging study. Dutch Barnidipine Multicenter Study Group. Cardiovasc Drugs Ther 1997; 11: 637 - 643.
24. Naber FB, Hage R, Mortelmans J: Barnidipine monotherapy and combination therapy in older patients with essential hypertension: A long-term study. Int J Clin Prac 2000; 114 (Suppl): 27 - 35.
25. Spieker C: Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension. Blood Press 1998; 7 (Suppl 1): 15-21.
26. Van Zwieten PA: Pharmacological prAfile of barnidipine: a single optical isomer dihydropyridine calcium antagonist. Blood Press 1998; 7 (Suppl 1): 5 - 8.
27. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A: Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: Additional information from a large data base. Blood Press 1995; 4: 148 - 156.
28. Coats AJ, Radaelli A, Clark SJ, Conway J, Sleight P: The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992; 10: 385 - 391.
29. Reid JL, Bainbridge AD, MacFadyen RJ: The contribution of ambulatory blood pressure measurement to the evaluation of new antihypertensive drugs. J Hypertens 1991; 9 (Suppl 8): S54-S56.
30. Floras JS: Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia. Lancet 1988; 2: 994 - 996.
31. Watanabe N, Imai Y, Nagai K, Tsuji I, Satoh H, Sakuma M, et al: Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996; 27: 1319 - 1327.
32. Imai Y, Abe K, Nishiyama A, Sekino M, Yoshinaga K: Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime. Am J Hypertens 1997; 10: 1415 - 1419.
33. White WB: Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens 1991; 9 (Suppl 1): S27 - S32.